negative regulation of hyaluronan biosynthetic process

Definition

Target type: biologicalprocess

Any process that stops, prevents or reduces the frequency, rate or extent of hyaluronan biosynthetic process. [GOC:TermGenie, GOC:yaf]

Negative regulation of hyaluronan biosynthetic process refers to the mechanisms that suppress or inhibit the production of hyaluronan, a large, unbranched polysaccharide crucial for various biological functions. Hyaluronan synthesis is primarily regulated by the enzyme hyaluronan synthase (HAS), which catalyzes the polymerization of glucuronic acid and N-acetylglucosamine monomers. Negative regulation of this process can occur at various levels, including:

**1. Transcriptional Regulation:**

* **Downregulation of HAS gene expression:** Several factors, including cytokines like transforming growth factor-beta (TGF-β) and tumor necrosis factor-alpha (TNF-α), can suppress HAS gene transcription, leading to reduced HAS enzyme production.
* **Regulation by microRNAs:** Certain microRNAs (miRNAs) can target HAS mRNA for degradation, thereby reducing HAS protein levels.

**2. Post-translational Regulation:**

* **Protein phosphorylation:** Phosphorylation of HAS proteins can alter their activity and stability, leading to decreased hyaluronan synthesis.
* **Protein degradation:** Specific proteases can degrade HAS proteins, reducing their enzymatic activity.

**3. Inhibition of HAS Enzyme Activity:**

* **Competitive inhibitors:** Molecules that bind to the active site of HAS enzymes and prevent substrate binding can inhibit hyaluronan synthesis.
* **Non-competitive inhibitors:** Molecules that bind to HAS enzymes at a site distinct from the active site can alter their conformation and reduce their activity.

**4. Regulation by Hyaluronan Degradation:**

* **Hyaluronidases:** A family of enzymes specifically degrade hyaluronan, reducing its concentration and providing a negative feedback loop to regulate its synthesis.

**5. Regulation by Cell Signaling Pathways:**

* **TGF-β signaling:** Activation of the TGF-β pathway can suppress HAS expression and activity, contributing to negative regulation of hyaluronan synthesis.
* **Wnt signaling:** Wnt signaling pathways have been implicated in both positive and negative regulation of hyaluronan synthesis, depending on the specific pathway and cellular context.

**6. Cellular Context-Specific Regulation:**

* **Developmental regulation:** Hyaluronan synthesis is tightly regulated during embryonic development, with specific patterns of expression and activity depending on tissue and developmental stage.
* **Disease states:** Aberrant regulation of hyaluronan synthesis is observed in various diseases, including cancer, inflammation, and fibrosis.

Overall, the negative regulation of hyaluronan biosynthetic process is a complex and multifaceted process involving multiple regulatory mechanisms. These mechanisms ensure that hyaluronan levels are tightly controlled and maintained within physiological ranges, contributing to tissue homeostasis and proper cellular function.'
"

Proteins (1)

Compounds (1)